|
PGRMC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.052050E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.192300E-02 |
| Normal-vs-Stage2 |
4.317800E-02 |
| Normal-vs-Stage3 |
7.580300E-03 |
| Normal-vs-Stage4 |
1.605660E-02 |
| Stage1-vs-Stage2 |
4.435200E-01 |
| Stage1-vs-Stage3 |
1.991840E-01 |
| Stage1-vs-Stage4 |
3.307400E-01 |
| Stage2-vs-Stage3 |
8.769400E-01 |
| Stage2-vs-Stage4 |
8.853400E-01 |
| Stage3-vs-Stage4 |
9.892000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.168060E-02 |
| Normal-vs-AfricanAmerican |
8.490200E-01 |
| Normal-vs-Asian |
9.746100E-02 |
| Caucasian-vs-AfricanAmerican |
2.237000E-01 |
| Caucasian-vs-Asian |
7.843200E-01 |
| AfricanAmerican-vs-Asian |
3.508600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.578000E-03 |
| Normal-vs-Female |
2.267700E-02 |
| Male-vs-Female |
3.815000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.710440E-01 |
| Normal-vs-Age(41-60Yrs) |
1.034260E-02 |
| Normal-vs-Age(61-80Yrs) |
1.239770E-03 |
| Normal-vs-Age(81-100Yrs) |
9.644000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.192000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.737600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.905600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.435400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.984000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.229030E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.563900E-04 |
| Classical-VS-Follicular |
3.615700E-03 |
| Classical-VS-Other |
2.862600E-01 |
| Classical-VS-Normal |
2.290000E-01 |
| Tall-VS-Follicular |
4.424400E-01 |
| Tall-VS-Other |
7.393000E-01 |
| Tall-VS-Normal |
2.975600E-04 |
| Follicular-VS-Other |
9.414800E-01 |
| Follicular-VS-Normal |
1.620940E-03 |
| Other-VS-Normal |
9.052500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.317970E-02 |
| Normal-vs-N1 |
3.158300E-03 |
| N0-vs-N1 |
2.779000E-01 |
|
|
